Reversible hepatic dysfunction in association with cyclophosphamide therapy.
A 5.5-year-old child with nephrotic syndrome was treated with cyclophosphamide. After 9 weeks of therapy she developed jaundice and abnormal liver function tests. No infective aetiology was found and the abnormal liver function tests resolved within 5 weeks of discontinuing cyclophosphamide. Cyclophosphamide has rarely been reported to cause liver dysfunction, but not in children treated for nephrotic syndrome, and paediatricians should therefore be aware of its potential for inducing reversible hepatic dysfunction.
Milford
D V
DV
Department of Nephrology, Children's Hospital, Birmingham, UK.
Butler
N
N
Clarke
R
R
Vaid
J
J
D002675:Child, Preschool; D002927:Cimetidine / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008111:Liver Function Tests; D009404:Nephrotic Syndrome / Q000188:drug therapy*
D002927:Cimetidine; D003520:Cyclophosphamide